Steven Michael Oliveira insider trades: Benitec Biopharma (BNTC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | BNTC | ↑ Buy | 331,877 | $4.51 | $1.5M | Through Nemean Asset Management, LLC | Dec 9, 2021 (0d) |
| Apr 14, 2020 | TOCA | ↑ Buy | 74,301 | $1.19 | $88K | By Steven Oliveira Roth IRA | Apr 14, 2020 (0d) |
| Mar 2, 2020 | TOCA | ↑ Buy | 65,149 | $1.35 | $88K | By Steven Oliveira Roth IRA | Mar 3, 2020 (1d) |
| May 20, 2009 | IGC | ↓ Sell | 423,986 | $0.97 | $411K | Indirect | May 21, 2009 (1d) |
| May 19, 2009 | IGC | ↓ Sell | 1,113,025 | $1.18 | $1.3M | Indirect | May 20, 2009 (1d) |
| Mar 10, 2008 | ICG | ↓ Sell | 145,800 | $4.05 | $591K | Indirect | Mar 11, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BNTC insiders
Open-market trades in the last 12 months
About Steven Michael Oliveira's insider trades
Steven Michael Oliveira is a 10% owner of Benitec Biopharma (BNTC). Since Mar 10, 2008, Steven has reported 3 open-market purchases worth $1.7M and 3 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BNTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.